Synthesis and characterization of high-molecular mass polyethylene glycol-conjugated oligonucleotides

Bioconjugate Chemistry

Volumn 8, Issue 6, 1997, Pages 793-797

  Bonora, Gian Maria ^a   Ivanova, Eugenia ^b   Zarytova, Valentina ^b   Burcovich, Barbara ^c   Veronese, Francesco Maria ^c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHAINS; DISEASES; DRUG DELIVERY; MOLECULAR MASS; NUCLEIC ACIDS; POLYETHYLENE GLYCOLS; POLYETHYLENES; SYNTHESIS (CHEMICAL);

CELLULAR TARGETS; CONJUGATED MOLECULES; HIGH MOLECULAR MASS; IN-VIVO; LIQUID PHASIS; LONG CHAINS; SCALED-UP; SHORTER CHAINS; SOLID-PHASE SUPPORTS; SYNTHESIS AND CHARACTERIZATIONS;

OLIGONUCLEOTIDES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031281253     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc970082p     Document Type: Article

References (32)

1. Cohen, J. S. (1992) Oligonucleotide therapeutics. Tibtech 10, 87.
2. Gillespie, D. (1992) Perspectives for antisense nucleic acid therapy. DN&P 7, 389.
3. Thuong, N. T., and Hélène, C. (1993) Sequence-specific recognition and modification of double-helical DNA by oligonucleotides. Angew. Chem., Int. Ed. Engl. 32, 666.
4. Wyatt, J. R., Vickers, T. A., Roberson, J. L., Buckeit, R. W., Klimkait, T., Deboets, E., Davis, P. W., Rayner, B., Imbach, J. L., and Eckers, D. J. (1994) Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc. Natl. Acad. Sci. U.S.A. 91, 1356.
5. Heidenreich, O., Kang, S.-H., Xu, X., and Nerenberg, M. (1995) Application of antisense technology to therapeutics. Mol. Med. Today 1, 128.
6. Sanghvi, Y. S., and Cook, P. D., Eds. (1994) Carbohydrate modifications in antisense research. ACS Symposium Series 580, Maple Press, York, PA.
7. Shea, R. G., Marsters, J. C., and Bischofberger, N. (1990) Synthesis, hybridization properties and antiviral activity of lipid-oligodeoxynucleotide conjugates. Nucleic Acids Res. 18, 3777.
8. Boutorin, A., Guskova, L., Ivanova, E., Kobetz, N., Zarytova, V., Ryte, A., Yurchenko, L., and Vlassov, V. (1989) Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3′-terminus and their interaction with DNA within mammalian cells. FEBS Lett. 254, 129.
9. Manoharan, M., Johnson, L. K., Bennett, C. F., Vickers, T. A., Ecker, D. J., Cowsert, L. M., Freier, S. M., and Cook, P. D. (1994) Cholic acid oligonucleotide conjugates for antisense application. Bioorg. Med. Chem. Lett. 18, 3777.
10. Tung, C., Rudolph, M. J., and Stein, S. (1991) Preparation of oligonucleotide-peptide conjugates. Bioconjugate Chem. 2, 464.
11. Harris, J. M., Ed. (1992) Poly(ethylene glycol) chemistry. Biotechnical and biomedical applications, Plenum Press, New York.
12. (a) Zalipsky, S. (1995) Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. Bioconjugate Chem. 6, 150.
13. (b) Zalipsky, S. (1995) Chemistry of polyethylene glycol conjugates with biologically active molecules. Adv. Drug Delivery Rev. 16, 157.
14. Kessler, D. J., Petitt, B. M., Cheng, Y.-K., Smith, S. R., Jayaraman, K., Vu, H. M., and Hogan, M. E. (1993) Triple helix formation at distant sites: hybrid oligonucleotides containing a polymeric linker. Nucleic Acids Res. 21, 4810.
15. Thomson, J. B., Tuschl, T., and Eckstein, F. (1993) Activity of hammerhead ribozymes containing non-nucleotidic linkers. Nucleic Acids Res. 21, 5600.
16. Rumney, S., IV, and Kool, E. T. (1995) Structural optimization of non-nucleotidic loop replacement for duplex and triplex DNAs. J. Am. Chem. Soc. 117, 5635.
17. Efimov, V. A., Pashkova, I. N., Kalinkina, A. L., and Chakhmakhcheva, O. G. (1993) Synthesis of conjugates of oligonucleotides with polyethylenglycol. Bioorg. Khimi. 19, 800.
18. Bayer, E., Maier, M., Bleicher, K., and Gaus, H. J. (1995) Synthesis of 3′ PEG modified oligonucleotides on PS PEG tentacle polymers. Z. Naturforsch. B 50, 671.
19. De Napoli, L., Di Fabio, G., Messere, A., Varra, M., and Piccialli, G. (1996) New solid-phase approach to obtain 3′-derivatized oligonucleotides. Gazz. Chim. Ital. 126, 755.
20. Jäschke, A., Fürste, J. P., Nordhoff, E., Hillenkamp, F., Cech, D., and Erdmann, V. A. (1994) Synthesis and properties of oligodeoxyribonucleotide-polyethylene glycol conjugates. Nucleic Acids Res. 22, 4810.
21. Jäschke, A., Bold, R., Nordhoff, E., Hillenkamp, F., Cech, D., Erdmann, V. A., and Fürste, J. P. (1996) Synthesis and analytical characterization of RNA-polyethylene glycol conjugates. Nucleosides Nucleotides 15, 1519
22. Tarasow, T. M., Timmermeier, D., and Zyrniewski, C. (1997) Characterization of oligodeoxyribonucleotides-polyethylene glycol conjugates by EMS. Bioconjugate Chem. 8, 89.
23. Manoharan, M., Tivel, K. L., Andrade, L. K., Mohan, V., Condon, T. P., Bennett, F. C., and Cook, P. D. (1995) Oligonucleotide conjugates: alteration of the pharmacokinetic properties of antisense agents. Nucleosides Nucleotides 14, 969.
24. Kawaguchi, T., Asakana, H., Tashiro, Y., Juni, K., and Sueishi, T. (1995) Stability, specific binding cativity, and plasma concentration in mice of an oligodeoxynucleotide modified at 5′-terminal with poly(ethylene glycol). Biol. Pharm. Bull. 18, 474.
25. Rahman, M. A., Summerton, J., Foster, E., Cunningham, K., Stirchak, E., Weller, D., and Schaup, H. W. (1991) Antibacterial activity and inhibition of protein synthesis in E. coli by antisense DNA analogs. Antisense Res. Dev. 1, 319.
26. Jones, D. S., Hachmann, J. P., Osgood, S. A., Hayaag, M. S., Barstad, P. A., Iverson, G. M., and Coutts, S. M. Conjugates of double-stranded oligonucleotides with poly(ethyleneglycol) and keyhole limpet hemocyanin: a model for treating systemic lupus erythematosus. Bioconjugate Chem. 5, 390.
27. Ravikumar, V. T., Andrade, M., Wyrzykiewicz, T., Scozzari, A., and Cole, D. L. (1995) Large-scale synthesis of oligodeoxyribonucleotide phosphorothioate using controlled-pore glass as support. Nucleosides Nucleotides 14, 1219.
28. Bonora, G. M. (1995) Polyethylene glycol. A high efficiency liquid phase (HELP) for the large-scale synthesis of oligonucleotides. Appl. Biochem. Biotechnol. 54, 3.
29. Svinarchuk, F. P., Konevetz, D. A., Pliasunova, O. A., Pokrovsky, A. G., and Vlassov, V. V. (1993) Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups. Biochimie 75, 49.
30. Bonora, G. M., Biancotto, G., Maffini, M., and Scremin, C. L. (1993) Large scale, liquid phase synthesis of oligonucleotides by the phosphoramidite approach. Nucleic Acids Res. 21, 1213.
31. Lokhov, S., Podyminogin, M., Sergeev, D., Silnikov, V., Kutyavin, I., Shishkin, G., and Zarytova, V. (1992) Synthesis and high stability of complementary complexes of N-(2-hydroxyethyl)phenazinium derivatives of oligonucleotides. Bioconjugate Chem. 3, 414.
32. Bagno, A., Bicciato, S., Dal Bosco, M., Bonora, G. M., and Di Bello, C. (1996) Apparecchiatura e processo per la sintesi automatica di oligomeri in fase liquida. Italian Patent Appl. MI96A001301.